Despite this being the first study evaluating the relation between the NAFLD and ANGPTL-8 in patients with acromegaly, this result supports the hypothesis that ANGPTL-8 may elevate as a compensatory response to the disturbed metabolic profile rather than being a cause in the pathophysiology of NAFLD. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.